Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a company dedicated to ending obesity, today announced that it has received an Issue Notification from the U.S. Patent and ...

Dubai – It has taken more than a decade for a 59-year-old Sudanese woman with achalasia, a rare oesophageal disorder, to ...

The market for GLP-1 drugs is projected to exceed $200 billion in annual sales by 2031, according to Morningstar Equity Research. Current market leaders include Novo Nordisk NVO and Eli Lilly LLY with ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat substance abuse disorders, psychosis, infections, cancer, and dementia.

More than one-third of websites selling their own versions implied the products were the same as the FDA-approved drugs.

Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study ...

“Weight loss that is not sustainable compromises your body’s capacity to function optimally. Instead of improving on health, it puts you at a risk of developing health issues. So do the right thing by ...

Weight-loss drugs have been rolled out by the NHS, but many are buying them through social media and online pharmacies ...

In the quest for effective weight loss solutions, many individuals find themselves overwhelmed by the sheer volume of ...

Are you trying to shed off those extra kilos? Check out empty stomach vs. post-meal walks: which one is more effective for ...